Matthew T. David
Chief Financial Officer · Actinium Pharmaceuticals, Inc.
Individual
- 2026
- Oct 16, 2026
- 1
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Matthew T. David's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Robert W. Duggan - $51.45M in SMMT purchases and sales in the last 12 months
- Eric M. Dube - $50.82M in TVTX purchases and sales in the last 12 months
- HRTG GPE, LLC - $50.00M in KARD purchases and sales in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $49.42M in VOR purchases and sales in the last 12 months
- Robert B. Ford - $48.22M in ABT purchases and sales in the last 12 months
- Roger Adsett - $47.51M in INSM purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Matthew T. David?
Matthew T. David is a corporate insider, tracked as Chief Financial Officer of Actinium Pharmaceuticals, Inc. (ATNM). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Matthew T. David submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
